Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Dec;170(7):1277-8.
doi: 10.1111/bph.12474.

The background to this themed issue on neuropeptides

Julie Keeble  1
Affiliations
Editorial

The background to this themed issue on neuropeptides

Julie Keeble. Br J Pharmacol. 2013 Dec.

Abstract

A meeting of the British Pharmacological Society in association with the European Neuropeptide Club and Americal Summer Neuropeptide Conference in June 2012 led to this themed issue on neuropetides. A wide range of neuropeptides are discussed, in various physiological and pathophysiological conditions, with respect to their upstream and downstream pathways. It is clear, at this point in time, that targeting neuropeptides has therapeutic potential in pathologies ranging from migraine to obesity. It is also clear from the reviews in this issue of the British Journal of Pharmacology that there is still so much to learn.

Linked articles: This article is part of a themed section on Neuropeptides. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2013.170.issue-7.

Keywords: CGRP; GPCR; TRPV1; motilin; neuropeptides; pituitary adenylyl cyclase-activating peptide; substance P; vasoactive intestinal peptide.

PubMed Disclaimer

References

    1. Bodkin JV, Fernandes ES. TRPV1 and SP: key elements for sepsis outcome? Br J Pharmacol. 2013;170:1279–1292. - PMC - PubMed
    1. Boughton CK, Murphy KG. Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity. Br J Pharmacol. 2013;170:1333–1348. - PMC - PubMed
    1. Cottrell G. Roles of proteolysis in regulation of GPCR function. Br J Pharmacol. 2013;168:576–590. - PMC - PubMed
    1. Sanger GJ, Wang Y, Hobson A, Broad J. Motilin: toward a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists. Br J Pharmacol. 2013;170:1323–1332. - PMC - PubMed
    1. Walker CS, Hay DL. CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors? Br J Pharmacol. 2013;170:1293–1307. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources